A drug called midostaurin could offer hope to patients with rare blood cancers known as advanced systemic mastocytosis.
royaltystockphoto/Shutterstock
A drug called midostaurin could offer hope to patients with rare blood cancers known as advanced systemic mastocytosis.
royaltystockphoto/Shutterstock